Your browser is no longer supported. Please, upgrade your browser.
NVO Novo Nordisk A/S daily Stock Chart
Novo Nordisk A/S
Index- P/E19.64 EPS (ttm)2.43 Insider Own26.40% Shs Outstand1.92B Perf Week-1.83%
Market Cap91.29B Forward P/E18.56 EPS next Y2.57 Insider Trans0.00% Shs Float1.32B Perf Month3.16%
Income5.91B PEG2.40 EPS next Q0.61 Inst Own9.10% Short Float0.33% Perf Quarter9.82%
Sales16.96B P/S5.38 EPS this Y2.80% Inst Trans-0.03% Short Ratio2.79 Perf Half Y-5.12%
Book/sh3.03 P/B15.73 EPS next Y3.30% ROA38.30% Target Price49.41 Perf Year-15.53%
Cash/sh- P/C- EPS next 5Y8.20% ROE80.50% 52W Range41.23 - 58.37 Perf YTD3.43%
Dividend1.27 P/FCF27.02 EPS past 5Y14.60% ROI74.60% 52W High-18.37% Beta0.74
Dividend %2.67% Quick Ratio0.80 Sales past 5Y7.40% Gross Margin84.00% 52W Low15.57% ATR0.87
Employees43161 Current Ratio1.10 Sales Q/Q4.30% Oper. Margin42.20% RSI (14)57.56 Volatility1.09% 1.51%
OptionableYes Debt/Eq0.01 EPS Q/Q-5.60% Profit Margin34.90% Rel Volume0.82 Prev Close47.65
ShortableYes LT Debt/Eq0.00 EarningsJan 31 BMO Payout295.10% Avg Volume1.54M Price47.65
Recom3.00 SMA202.16% SMA504.12% SMA2001.49% Volume0 Change0.00%
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Dec-29-17Upgrade JP Morgan Underweight → Neutral
Dec-06-17Upgrade BofA/Merrill Neutral → Buy
Dec-01-17Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-25-17Downgrade Exane BNP Paribas Outperform → Neutral
Sep-06-17Upgrade BofA/Merrill Underperform → Neutral
Oct-31-16Downgrade DNB Markets Buy → Hold
Oct-31-16Downgrade Citigroup Buy → Neutral
Oct-28-16Downgrade BofA/Merrill Neutral → Underperform
Sep-23-16Initiated Piper Jaffray Neutral
Sep-13-16Upgrade Exane BNP Paribas Neutral → Outperform
Sep-09-16Downgrade JP Morgan Overweight → Neutral
Sep-01-16Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-31-16Upgrade HSBC Securities Reduce → Hold
Aug-08-16Downgrade BofA/Merrill Buy → Neutral
Aug-28-15Initiated Leerink Partners Mkt Perform $56
Jun-09-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-15-15Initiated Societe Generale Sell
May-28-13Upgrade Deutsche Bank Sell → Hold
Jan-15-19 09:30PM  3 Top Diabetes Stocks to Watch in January Motley Fool
Jan-14-19 12:20PM  6 Bargain Stocks With Positive Earnings Growth Estimates
12:09PM  House Democrats launch drug-pricing probe into a dozen major health-care companies CNBC
Jan-11-19 05:36PM  5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019 Zacks
Jan-10-19 09:25PM  J&J raises U.S. prices on around two dozen drugs Reuters
06:49AM  [$$] Sanofi and Novo Nordisk press ahead with US insulin prices rises Financial Times
Jan-08-19 06:03PM  Thoughts on 2018 Performance
Jan-03-19 09:30AM  Novo Nordisk Boasts Strong Diabetes Presence and Pipeline Zacks
Dec-26-18 02:22PM  6 Valuable Pipeline Drugs With Upcoming Catalysts Benzinga
Dec-22-18 09:00AM  As obesity rates in America soar, new weight loss drugs are in the offing that offer hope CNBC
Dec-19-18 11:15AM  Strongbridge completes $181.7M sale of hormone drug to Novo Nordisk American City Business Journals
12:39AM  Here is What Hedge Funds Think About Novo Nordisk A/S (NVO) Insider Monkey
Dec-18-18 07:17AM  3 Biotechs With Potential Blockbusters Near the Finish Line Motley Fool
Dec-17-18 03:28PM  [$$] Staten Biotechnology Strikes $488 Million Deal With Novo The Wall Street Journal
Dec-05-18 08:53AM  Novo Nordisk announces another $22M investment in Clayton American City Business Journals
Nov-27-18 05:47PM  Zafgen (ZFGN) Plunges as FDA Puts Hold on Diabetes Drug Trial Zacks
Nov-21-18 08:15AM  The Zacks Analyst Blog Highlights: Sanofi, Novo Nordisk, NVIDIA, Fifth Third Bancorp and Continental Resources Zacks
Nov-14-18 06:53AM  Novo Nordisk A/S (NVO): Hedge Fund Sentiment Going Nowhere Insider Monkey
Nov-08-18 02:53PM  Novo Nordisk Continues Its Balancing Act Motley Fool
Nov-01-18 04:56PM  Novo Nordisk (NVO) Reports In-Line Q3 Earnings, Beats Sales Zacks
01:07PM  [$$] Danish Insulin Maker Novo Nordisk Cuts Jobs, Shifts R&D Spending The Wall Street Journal
12:36PM  Novo Nordisk (NVO) Q3 2018 Earnings Conference Call Transcript Motley Fool
05:59AM  Upbeat sales lift Novo Nordisk as drugmaker weathers U.S. pricing pressure Reuters
05:04AM  Novo Nordisk: 3Q Earnings Snapshot Associated Press
02:57AM  Novo Nordisk earnings miss expectations amid currency headwinds CNBC
Oct-31-18 02:56PM  Q3 Earnings Preview For Novo Nordisk Benzinga
Oct-26-18 08:45AM  Investor Expectations to Drive Momentum within Paratek Pharmaceuticals, Dell Technologies, Dover, Black Hills, Kinder Morgan, and Novo Nordisk A/S Discovering Underlying Factors of Influence GlobeNewswire
Oct-22-18 05:26PM  5 Undervalued Companies With Predictable Businesses
Oct-18-18 09:27AM  Novo Nordisk (NVO) Faces Pricing Pressure and Competition Zacks
Oct-16-18 08:50PM  Minnesota accuses insulin makers of deceptive drug pricing Reuters
05:10PM  Minnesota accuses insulin makers of deceptive drug pricing Reuters
Oct-15-18 04:37PM  6 Companies Growing Their Book Value
09:32AM  Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit Reuters
09:30AM  PFE or NVO: Which Is the Better Value Stock Right Now? Zacks
08:20AM  Novo Nordisk could close biopharma acquisition this year - CEO Reuters
Oct-08-18 07:30AM  The Week Ahead In Biotech: Conferences, Clinical Trial Results And IPOs Benzinga
Oct-05-18 09:54AM  Lilly's Novel Diabetes Candidate Shows Promise in Phase II Zacks
Oct-04-18 02:24PM  7 Healthcare Stocks to Buy Right Now InvestorPlace -7.35%
09:55AM  Lilly's diabetes drug data impresses, hurts rival Novo's shares Reuters
08:57AM  Diabetes Drug's Results Push Lilly to Look at Obesity Too Bloomberg
Sep-28-18 07:58AM  Novo Nordisk to cut 250 jobs in the United States Reuters
07:29AM  Novo Nordisk to cut 250 jobs in the United States Reuters
Sep-27-18 11:33AM  Investing in Diabetes Stocks: A Beginner's Guide Motley Fool
08:00AM  Government of Quebec provides adults living with diabetes mellitus access to ultra-long-acting insulin, TRESIBA® CNW Group
Sep-21-18 08:12AM  Ontario becomes first province to provide public funding of TRESIBA® for adults with diabetes mellitus CNW Group
Sep-19-18 08:48AM  Novo Nordisk to Restructure R&D Unit & Lay Off 400 Staff Zacks
Sep-18-18 02:06PM  Danish pharma giant Novo Nordisk to open first Mass. office American City Business Journals
05:11AM  Novo Nordisk lays off 400 staff in research & development unit Reuters
01:07AM  [$$] Novo Nordisk sheds 400 staff as it refocuses R&D efforts Financial Times
Sep-17-18 06:13PM  3 High-Quality Biotech Companies for 4th Quarter
Sep-14-18 02:04AM  Novo Nordisk CEO: Increasing inventories in anticipation ... CNBC Videos
Sep-12-18 06:00AM  EyePoint Pharmaceuticals Reports Fiscal 2018 Fourth Quarter & Full Year Financial Results and Highlights Recent Progress GlobeNewswire
Sep-10-18 07:00AM  EyePoint Pharmaceuticals Elects Göran Ando, M.D. as Next Chairman of Board of Directors GlobeNewswire
Sep-04-18 02:05PM  Novo Nordisk's Ozempic Lowers Risk of Cardiovascular Events (revised) Zacks
Aug-27-18 09:30AM  Novo Nordisk's Ozempic Lowers Risk of Cardiovascular Events Zacks
Aug-24-18 08:54AM  Pharma Stock Roundup: FDA Blow for AGN, Label Expansion Nod for MRK, BMY Cancer Drugs Zacks
Aug-20-18 04:47PM  Novo Nordisk Buys Ziylo to Develop Glucose Responsive Insulin Zacks
Aug-17-18 12:24AM  [$$] Novo Nordisk buys UK university biotech spin-out Ziylo Financial Times
Aug-14-18 04:22PM  Novo Nordisk's Pricing Pressures Aren't Going Away Motley Fool
Aug-13-18 07:38AM  The Zacks Analyst Blog Highlights: Novo Nordisk, J&J, Allergan, Editas, AstraZeneca, Merck and Bristol-Myers Zacks
Aug-10-18 11:18AM  Novo Nordisk (NVO) Q2 2018 Earnings Conference Call Transcript Motley Fool
08:52AM  Pharma Stock Roundup: NVO Q2 Earnings, JNJ, AGN & AZN's Pipeline Updates in Focus Zacks
08:08AM  Eli Lilly Stock History Motley Fool
Aug-08-18 11:12AM  Amazon, Novo Nordisk and Tesla are the Yahoo Finance charts of the day. Yahoo Finance Video -6.21%
10:42AM  Novo Nordisk (NVO) Beats Q2 Earnings and Sales Estimates Zacks
05:40AM  [$$] European Corporate Roundup for Wednesday The Wall Street Journal
05:33AM  Novo Nordisk: 2Q Earnings Snapshot Associated Press
04:45AM  Novo Nordisk CEO Sees Demand for Better Products Bloomberg Video
04:45AM  Novo Nordisk CEO Sees Demand for Better Products Bloomberg
Aug-07-18 10:15PM  [$$] Shares in Novo Nordisk fall after warning on US price cuts Financial Times
09:30AM  BMY vs. NVO: Which Stock Is the Better Value Option? Zacks
Jul-19-18 09:50AM  LLY vs. NVO: Which Stock Is the Better Value Option? Zacks
09:45AM  LLY vs. NVO: Which Stock Is the Better Value Option? Zacks
Jul-13-18 07:42AM  Novozymes and Novo Nordisk sign deal to source power from Denmarks largest wind farm CNBC
Jul-10-18 02:46PM  Drugmakers Cancel Price Hikes After California Law Takes Effect Bloomberg
Jul-06-18 12:59PM  Top Stocks Set to Disrupt the Diabetes Market Motley Fool
Jul-05-18 07:25AM  Free Technical Reports on Novavax and Three Additional Biotech Equities ACCESSWIRE
Jun-30-18 05:32PM  The Week Ahead In Biotech: Delayed Clinical Trial Releases In Focus Benzinga
Jun-26-18 07:00AM  EyePoint Pharmaceuticals Appoints Göran Ando, M.D., to Board of Directors GlobeNewswire
Jun-25-18 09:12AM  Novo Nordisk (NVO) Announces Results in Diabetes Studies Zacks
Jun-24-18 06:31AM  5 Biggest Blockbuster Diabetes Drugs of the Future Motley Fool
Jun-23-18 11:01AM  Novo Says Tresiba Shows Significantly Better Blood Sugar Control Bloomberg
10:00AM  Novo reveals more Ozempic data on change in body weight by baseline BMI Reuters
Jun-22-18 08:02PM  Drug Pricing Turns to Insulin as Politicians, AMA and Docs Look to Pharma
09:52AM  Pharma Stock Roundup: PTCT Unveils Promising Data, RHHBY to Acquire Rest of FMI Zacks
Jun-21-18 05:33PM  Novo Nordisk Stock Rises 4% Over 2 Sessions
03:39PM  Novo Nordisk's (NVO) Oral Ozempic Positive in Diabetes Study Zacks
09:48AM  Novo Nordisk Stock Pops Nearly 3% on Positive Diabetes-Drug Results
Jun-20-18 05:51PM  Novo Nordisk in Deal with Kallyope for Obesity, Diabetes Drugs Zacks
09:30AM  LLY vs. NVO: Which Stock Should Value Investors Buy Now? Zacks
Jun-17-18 12:03PM  Big Pharma Stock Investors Beware: Another $250 Billion Patent Cliff Is Coming Motley Fool
Jun-08-18 03:53AM  Novo Nordisk shares fall after report of layoffs Reuters
May-31-18 10:58AM  Top Diabetes Stocks to Buy Today Motley Fool
08:49AM  Emisphere Development Update GlobeNewswire
May-30-18 08:28AM  Novo Nordisk's Oral Ozempic Positive in Diabetes Study Zacks
May-29-18 12:54PM  Novo Nordisk's oral diabetes drug beats Jardiance in study Reuters
May-25-18 06:32PM  How to Invest in Diabetes Stocks Motley Fool
05:38AM  Almost a quarter of the worlds population will be obese by 2045 MarketWatch
May-23-18 01:39PM  Eli Lilly's Trulicity Benefits From Growth of Diabetes Drugs
May-22-18 08:00AM  Report: Developing Opportunities within El Pollo Loco, Chemed, Novo Nordisk A/S, FactSet Research, Fair Isaac, and HCP Future Expectations, Projections Moving into 2018 GlobeNewswire
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Obesity, and Biopharmaceuticals. The Diabetes Care and Obesity segment provides insulins, GLP-1 and related delivery systems, and oral anti-diabetic drugs and obesity. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. Novo Nordisk A/S has a research and licensing agreement with DUKE National University Singapore Medical School to develop stem cell-based treatments for chronic heart failure and age-related macular degeneration; and a strategic alliance with Evotec AG to discover and develop small molecule therapies to treat patients suffering from diabetes, obesity, and co-morbidities, as well as has a research collaboration with Kallyope Inc. The company markets and distributes its products through distributors and independent agents. Novo Nordisk A/S has a collaboration agreement with Embark Biotech ApS for the discovery of novel treatments for obesity and its associated metabolic pathologies; and e-therapeutics plc to use network-driven drug discovery platform for discovering novel biological mechanisms and therapeutic approaches for a specific area of type-2 diabetes; and Staten Biotechnology B.V. to develop novel therapeutics for the treatment of hypertriglyceridaemia. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.